<DOC>
	<DOCNO>NCT02114372</DOCNO>
	<brief_summary>The purpose study investigate natural history cognitive functional change participant risk develop mild cognitive impairment ( MCI ) due Alzheimer 's disease ( AD ) ( MCI-AD ) .</brief_summary>
	<brief_title>Cognitive Health Ageing Register : Investigational , Observational Trial Studies Dementia Research : Prospective Readiness Cohort Study</brief_title>
	<detailed_description>This prospective single center study enroll participant without dementia consider high , medium low risk develop mild cognitive impairment ( MCI ) due Alzheimer 's disease ( AD ) community-based register ( referred CHARIOT registry ) United Kingdom . No intervention ( ie , study drug ) administer participant study . The planned duration study approximately 4 year 2 year participant recruitment . Data collection ass outcome measure associate disease progression occur baseline every 6 month thereafter clinic follow-up period 48 month . Blood , urine , saliva sample collect participant study biomarker analyse assess risk factor dementia , Alzheimer 's disease confounding factor dementia risk . Adverse event experience participant participation study monitor .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<criteria>Inclusion criterion : Enrolled CHARIOT Register Willing able give write informed consent Meets definition inclusion low risk , medium risk , high risk cohort accord criterion specify protocol Concurrent participation clinical trial Diagnosis Dementia Past current use memantine cholinesterase inhibitor Diagnosis neurologic disease condition know cause associate dementia , Parkinson 's disease History traumatic brain injury residual neurological deficit stroke</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Mild Cognitive Impairment ( MCI )</keyword>
</DOC>